s6y IRulya Therapeutics Inc. EFFECT

IRulya Therapeutics Inc. EFFECT, filed Aug 24, 2026: primary_doc.xml

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: August 24, 2026 4:00 P.M.
Form: S-3
CIK: 0001662774
Company Name: Quince Therapeutics, Inc.
File Number: 333-297903